Literature DB >> 8981684

An application of a marked point process in pre-clinical medicine.

D M Berridge1.   

Abstract

Several authors have employed marked point processes to model complex survival time data. In this paper it is proposed to illustrate further the flexibility of marked point processes by using such a framework to model pre-clinical data which comprise survival times accompanied by ordinal outcomes.

Mesh：

Substances：

Year:  1996        PMID： 8981684     DOI： 10.1002/(SICI)1097-0258(19961230)15:24<2751::AID-SIM497>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Stat Med        ISSN： 0277-6715            Impact factor:   2.373


  2 in total

1.  Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.

Authors:  Nickhill Bhakta; Qi Liu; Frederick Yeo; Malek Baassiri; Matthew J Ehrhardt; Deo K Srivastava; Monika L Metzger; Matthew J Krasin; Kirsten K Ness; Melissa M Hudson; Yutaka Yasui; Leslie L Robison
Journal:  Lancet Oncol       Date:  2016-07-25       Impact factor: 41.316

2.  The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE).

Authors:  Nickhill Bhakta; Qi Liu; Kirsten K Ness; Malek Baassiri; Hesham Eissa; Frederick Yeo; Wassim Chemaitilly; Matthew J Ehrhardt; Johnnie Bass; Michael W Bishop; Kyla Shelton; Lu Lu; Sujuan Huang; Zhenghong Li; Eric Caron; Jennifer Lanctot; Carrie Howell; Timothy Folse; Vijaya Joshi; Daniel M Green; Daniel A Mulrooney; Gregory T Armstrong; Kevin R Krull; Tara M Brinkman; Raja B Khan; Deo K Srivastava; Melissa M Hudson; Yutaka Yasui; Leslie L Robison
Journal:  Lancet       Date:  2017-09-08       Impact factor: 79.321
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.